Related Experiment Videos
Angiogenesis and endometrial cancer
1Department of Pathology, Democritus University of Thrace, Alexandroupolis, Greece. esivrid@med.duth.gr
Anticancer Research
|March 23, 2002
Summary
Increased angiogenesis, driven by vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP), is linked to poor prognosis in endometrial cancer. The combined activity of VEGF and TP at the tumor front is a potent indicator of this aggressive phenotype.
Area of Science:
- Gynecologic Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Angiogenesis is more frequent in endometrial carcinomas with atrophy than hyperplasia.
- Increased angiogenesis correlates with poor prognosis in endometrial cancer, though its association with histopathological features varies.
- Vascular Endothelial Growth Factor (VEGF) is a key driver of angiogenesis in endometrial carcinomas.
Purpose of the Study:
- To investigate the prognostic significance of angiogenesis and its key regulators, VEGF and thymidine phosphorylase (TP), in endometrial carcinomas.
- To determine the relationship between VEGF/flk-1 (KDR) pathway and TP expression with clinicopathological features and patient outcomes.
- To identify the most potent angiogenic phenotype in endometrial carcinomas.
Main Methods:
- Analysis of angiogenesis, VEGF expression, and TP activity in endometrial carcinoma tissues.
- Correlation of angiogenic markers with histopathological features (tumor grade, myometrial invasion, stage).
- Assessment of the prognostic value of the VEGF/flk-1 (KDR) pathway and TP activity, particularly at the invading tumor front.
Main Results:
- VEGF expression is significantly higher at the invading tumor front and associated with poor prognosis, especially in stage I disease.
- The functional VEGF/flk-1 (KDR) pathway is a more reliable independent prognostic parameter than VEGF alone.
- High TP activity at the tumor front correlates with adverse features in non-endometrioid carcinomas and is promoted by macrophages, suggesting a co-operative angiogenic mechanism with VEGF.
Conclusions:
- The combined high expression of VEGF and high TP activity at the invading tumor front represents the most potent angiogenic phenotype in endometrial carcinomas.
- The VEGF/flk-1 (KDR) pathway and TP activity, especially in conjunction with tumor-associated macrophages, are critical determinants of endometrial tumor angiogenesis and prognosis.
- Targeting these co-operating angiogenic factors may offer novel therapeutic strategies for endometrial cancer.